Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies

NCT07345728 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Donghua Zhang